Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Why Byrna Could Be the Top Defense Stock to Watch Now
Why Byrna Could Be the Top Defense Stock to Watch Now

2025 has been a remarkable year for the defense industry. Look no further than a benchmark exchange-traded fund (ETF) like the Global X Defense Tech ETF (NYSEARCA: SHLD), which has returned about

Meta Platforms (META) Reports Q2 Earnings: What Key Metrics Have to Say
Meta Platforms (META) Reports Q2 Earnings: What Key Metrics Have to Say

Meta Platforms (META) reported $47.52 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 21.6%. EPS of $7.14 for the same period compares to $5.16 a year

QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration
QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration

Top executives and analysts focus on consistent earnings growth, which reflects a company’s profitability. However, earnings acceleration has an even greater impact on driving up stock prices

Bull Of The Day: OptimizeRX (OPRX)
Bull Of The Day: OptimizeRX (OPRX)

OptimizeRX (OPRX) is a Zacks Rank #1 (Strong Buy) that has an F for Value and an A for Growth. The company runs a health solutions platform that helps physicians and patients better afford and

Top Stock Reports for Costco, HSBC & Booking Holdings
Top Stock Reports for Costco, HSBC & Booking Holdings

Thursday, July 31, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco

Bear Of The Day: Albany International (AIN)
Bear Of The Day: Albany International (AIN)

Albany International (AIN) is a Zacks Rank #5 (Strong Sell) after the company recently posted a miss and the stock has plunged as a result.  This article will look at why this stock is a Zacks Rank

Medical Properties Q2 NFFO Misses Estimates, Revenues Fall Y/Y
Medical Properties Q2 NFFO Misses Estimates, Revenues Fall Y/Y

Medical Properties Trust, Inc. MPW — also known as MPT — reported second-quarter 2025 normalized funds from operations (NFFO) per share of 14 cents, missing the Zacks Consensus Estimate of 15 cents

Why Bloom Energy Stock Could Break to New Highs
Why Bloom Energy Stock Could Break to New Highs

Buying a stock as it’s pushing toward or breaking through a 52-week high can feel daunting, since above that price lies uncharted territory. Yet that’s often exactly when you should double down

Nasdaq Covered Call ETFs for Growth & Income
Nasdaq Covered Call ETFs for Growth & Income

Investors seeking higher income have been flocking to ETFs that use options to generate attractive dividends. There has been a recent surge in new products as providers develop innovative ways to

Will Top-Line Improvement Benefit Palantir in Q2 Earnings?
Will Top-Line Improvement Benefit Palantir in Q2 Earnings?

Palantir Technologies Inc. PLTR will report its second-quarter 2025  results on Aug. 4, after the bell.

We expect a significant year-over-year improvement in the company’s top line in the

NPK Q2 Earnings Down Y/Y As Tariffs Weigh, Sales up 42%
NPK Q2 Earnings Down Y/Y As Tariffs Weigh, Sales up 42%

Shares of National Presto Industries, Inc. NPK have declined 7.1% since the company reported its second quarter earnings for the period ended June 29, 2025. Over the same time frame, the S&P 500

FICO Q3 Earnings Beat Estimates, Strong Scores Drive Up Sales Y/Y
FICO Q3 Earnings Beat Estimates, Strong Scores Drive Up Sales Y/Y

Fair Isaac FICO reported third-quarter fiscal 2025 non-GAAP earnings of $8.57 per share, which surpassed the Zacks Consensus Estimate by 10.87% and jumped 37.1% year over year.Revenues of $536.4

Will PepsiCo's Focus on Premium Drinks Drive the Next Leg of Growth?
Will PepsiCo's Focus on Premium Drinks Drive the Next Leg of Growth?

PepsiCo, Inc. PEP is sharpening its competitive edge in the beverage category by doubling down on premium and functional drinks, aiming to ride the wave of evolving consumer preferences. As demand

PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?
PYPL Stock Falls 10% Post Q2 Earnings: Should You Buy, Hold or Fold?

PayPal Holdings PYPL is no stranger to market volatility, but the more than 10% post-earnings selloff following its second-quarter 2025 results caught many investors off guard. After delivering an

GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised

Glaukos Corporation GKOS reported second-quarter 2025 adjusted loss of 24 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 26 cents. The figure also improved from

CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised

CONMED Corporation CNMD delivered second-quarter 2025 adjusted earnings per share (EPS) of $1.15, which beat the Zacks Consensus Estimate of $1.13 by 1.8%. The bottom line improved 17.3% from the

Quanta Tops Q2 Earnings & Revenue Estimates, Lifts 2025 View
Quanta Tops Q2 Earnings & Revenue Estimates, Lifts 2025 View

Quanta Services, Inc. PWR posted a robust second-quarter 2025 performance, highlighted by double-digit revenue growth, margin expansion, and strategic capital deployment. The results reflect strong

AbbVie Stock Eyes Breakout as Pipeline and Profits Grow
AbbVie Stock Eyes Breakout as Pipeline and Profits Grow

AbbVie Inc. (NYSE: ABBV) stock is up nearly 2% in midday trading after delivering a beat-and-raise in its second-quarter 2025 earnings report. The biopharmaceutical giant reported global net

3 Business Services Stocks to Watch in a Prospering Industry
3 Business Services Stocks to Watch in a Prospering Industry
Economic strength, encouraging service activities, and increased adoption and success of the work-from-home trend enable the Zacks Business - Services industry players to support the demand
C.H. Robinson Q2 Earnings Surpass Estimates, Increase Year Over Year
C.H. Robinson Q2 Earnings Surpass Estimates, Increase Year Over Year

C.H. Robinson Worldwide, Inc. (CHRW) reported mixed second-quarter 2025 results, wherein earnings surpassed the Zacks Consensus Estimate while revenues missed the same.

Quarterly earnings per share

Gencor Stock Gains Following Q2 Earnings Amid Revenue Decline
Gencor Stock Gains Following Q2 Earnings Amid Revenue Decline

Shares of Gencor Industries, Inc. GENC have gained 4.1% since the company reported its earnings for the quarter ended March 31, 2025. This compares to the S&P 500 Index’s 0.1% gain over the same

Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes

The Cigna Group CI reported second-quarter 2025 adjusted earnings per share (EPS) of $7.20, which beat the Zacks Consensus Estimate by 0.8%. The bottom line advanced 7.1% year over year. 

Adjusted

Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands

Merit Medical Systems, Inc. MMSI reported second-quarter 2025 adjusted earnings per share (EPS) of $1.01, up 9.8% from the year-ago quarter. The bottom line surpassed the Zacks Consensus Estimate by

Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?

DaVita Inc. DVA is scheduled to report second-quarter 2025 results on Aug. 5, after the closing bell.

In the last reported quarter, the company’s earnings per share (EPS) of $2.00 beat the Zacks

Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare
Hims & Hers Leads the Charge in AI-Powered Personalized Healthcare

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building a next-generation, digital-first healthcare platform centered around personalization, accessibility and